BackProcaps Group S.A - Warrants (29/09/2026) Overview

Procaps Group S.A - Warrants (29/09/2026) EBIT

Track Procaps Group S.A - Warrants (29/09/2026)'s EBIT ($92M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$11.37M
↓ 34.45% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

$91.94M
↑ 2530.99% YoY

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Procaps Group S.A - Warrants (29/09/2026) (PROCW) FAQ

The latest EBIT for PROCW is $92M as of September 2023. That compares with $-3.8M in the prior-year period — up 2531.0% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Procaps Group S.A - Warrants (29/09/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PROCW's EBIT moved from $-3.8M to $92M — a 2531.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Procaps Group S.A - Warrants (29/09/2026)'s operating scale or balance-sheet position.

Against Healthcare companies, PROCW currently prints $92M for EBIT, while the sector average sits near $22B. That is roughly 99.6% below the sector mean. Large gaps often invite a closer look at Procaps Group S.A - Warrants (29/09/2026)'s growth, margins, and balance sheet.

A EBIT figure of $92M for PROCW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting PROCW's EBIT ($92M), review year-over-year change from $-3.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.